7301 |
7O85 |
NO_M |
cAb29 Fab |
Protective antigen (PA) |
Bacillus anthracis, Mus musculus |
EM |
3.3 | 10.1107/S2059798321007816 |
7302 |
7O85 |
QR_P |
cAb29 Fab |
Protective antigen (PA) |
Bacillus anthracis, Mus musculus |
EM |
3.3 | 10.1107/S2059798321007816 |
7303 |
7O85 |
TU_S |
cAb29 Fab |
Protective antigen (PA) |
Bacillus anthracis, Mus musculus |
EM |
3.3 | 10.1107/S2059798321007816 |
7304 |
7O85 |
BC_A |
cAb29 Fab |
Protective antigen (PA) |
Bacillus anthracis, Mus musculus |
EM |
3.3 | 10.1107/S2059798321007816 |
7305 |
7O85 |
EF_D |
cAb29 Fab |
Protective antigen (PA) |
Bacillus anthracis, Mus musculus |
EM |
3.3 | 10.1107/S2059798321007816 |
7306 |
7OAO |
B_A |
C5 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
1.5 | 10.1038/s41467-021-25480-z |
7307 |
7OAP |
A_B |
C1 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Lama glama, Severe acute respiratory syndrome coronavirus 2 |
XRD |
1.9 | 10.1038/s41467-021-25480-z |
7308 |
7OAP |
C_B |
H3 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Lama glama, Severe acute respiratory syndrome coronavirus 2 |
XRD |
1.9 | 10.1038/s41467-021-25480-z |
7309 |
7OAQ |
A_B |
C1 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Lama glama, Severe acute respiratory syndrome coronavirus 2 |
XRD |
1.55 | 10.1038/s41467-021-25480-z |
7310 |
7OAQ |
C_B |
H3 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Lama glama, Severe acute respiratory syndrome coronavirus 2 |
XRD |
1.55 | 10.1038/s41467-021-25480-z |
7311 |
7OAY |
L_K |
F2 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.34 | 10.1038/s41467-021-25480-z |
7312 |
7OAY |
B_A |
F2 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.34 | 10.1038/s41467-021-25480-z |
7313 |
7OAY |
F_E |
F2 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.34 | 10.1038/s41467-021-25480-z |
7314 |
7OAY |
H_G |
F2 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.34 | 10.1038/s41467-021-25480-z |
7315 |
7OAY |
D_C |
F2 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.34 | 10.1038/s41467-021-25480-z |
7316 |
7OAY |
J_I |
F2 Nanobody |
SARS-CoV-2 spike glycoprotein RBD |
Severe acute respiratory syndrome coronavirus 2, Lama glama |
XRD |
2.34 | 10.1038/s41467-021-25480-z |
7317 |
7OLZ |
B_A |
Re9F06 VHH |
SARS-CoV-2 spike glycoprotein RBD |
Vicugna pacos, Severe acute respiratory syndrome coronavirus 2 |
XRD |
1.75 | 10.15252/embj.2021107985 |
7318 |
7OLZ |
C_A |
Re5D06 VHH |
SARS-CoV-2 spike glycoprotein RBD |
Vicugna pacos, Severe acute respiratory syndrome coronavirus 2 |
XRD |
1.75 | 10.15252/embj.2021107985 |
7319 |
7P2D |
C_A |
hCD11bNb1 Nanobody |
Integrin receptor αM |
Homo sapiens, Lama glama |
XRD |
3.2 | 10.1016/j.jbc.2022.102168 |
7320 |
7PA5 |
B_A |
cAbCMY-2(254) VHH |
CMY-2 β-lactamase |
Escherichia coli, Camelidae |
XRD |
3.18 | 10.1128/aac.01499-22 |